Exagen Inc.

XGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.74

+$0.12 (+1.39%)

At close: Sep 22, 2026, 4:00 PM ET

$8.74

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.39%

(1D)

Rating

Updated: Aug 24, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $211.16M

1D Range

8.61 8.88

52W Range

2.59 12.23

Valuation (TTM)

PE -10.51

PB 17.05

EV/EBITDA -18.25

Valuation (NTM)

Forward PE N/A

Forward PEG 0.45

Price Target $8

Cash Flow

FCF Yield -3.6%

SBC Adj. FCF Yield -5.0%

SBC Impact -38.6%

Margins

Gross Margin 58.6%

Operating Margin -18.6%

FCF Margin -10.7%

Growth (CAGR)

Revenue 3Y | 5Y 10.3% | 8.7%

Dil EPS 3Y | 5Y 8.4% | 29.2%

FCF 3Y | 5Y -6.2% | 37.3%

Returns

ROA -36.4%

ROE -121.6%

ROIC -33.0%

Financial Health

Net Cash

$1.75M

Current Ratio 3.18

Interest Coverage -2.58

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the Uni...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 216

IPO Date Sep 18, 2019

Website www.exagen.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-8.47%

Buy (6)

Hold (0)

Sell (0)

Analyst Details ➞